| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/23/2011 | US20110150924 Device, Method, and system for neural modulation as vaccine adjuvant in a vertebrate subject |
| 06/23/2011 | US20110150923 Mucosal meningococcal vaccines |
| 06/23/2011 | US20110150922 Immunogen platform |
| 06/23/2011 | US20110150921 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 06/23/2011 | US20110150920 Allergy Vaccines Containing Hybrid Polypeptides |
| 06/23/2011 | US20110150919 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150918 Treatment of microbial infections |
| 06/23/2011 | US20110150917 Small Cationic Antimicrobial Peptides |
| 06/23/2011 | US20110150916 Compositions and methods for treatment of group a streptococci |
| 06/23/2011 | US20110150915 Polyvalent vaccine |
| 06/23/2011 | US20110150914 Compositions and methods for dengue virus (dv) treatment and vaccination |
| 06/23/2011 | US20110150913 Torque teno virus (ttv) isolates and compositions |
| 06/23/2011 | US20110150912 Avian influenza virus live attenuated vaccine and uses thereof |
| 06/23/2011 | US20110150911 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/23/2011 | US20110150909 Yeast-Based Vaccines As Immunotherapy |
| 06/23/2011 | US20110150908 Anti-cd70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders |
| 06/23/2011 | US20110150907 Methods and materials for gastrointestinal delivery of pathogen/toxin binding agents |
| 06/23/2011 | US20110150906 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
| 06/23/2011 | US20110150905 Human antibodies to human delta like ligand 4 |
| 06/23/2011 | US20110150904 Therapeutic Antibodies for Treatment and Prophylaxis of Transmittable Viral Diseases |
| 06/23/2011 | US20110150903 Fgf-r4 receptor-specific antagonists |
| 06/23/2011 | US20110150902 Treating cancer |
| 06/23/2011 | US20110150901 Binding proteins that bind to human fgfr1c, human beta-klotho and both human fgfr1c and human beta-klotho |
| 06/23/2011 | US20110150900 Regulation of fatty acid transporters |
| 06/23/2011 | US20110150899 Senescence control composition containing extracellular matrix components, and senescence control method for senescent cells using same |
| 06/23/2011 | US20110150898 EPHA2 as a therapeutic target for cancer |
| 06/23/2011 | US20110150897 Influenza targets |
| 06/23/2011 | US20110150896 Antibody against PCRV |
| 06/23/2011 | US20110150895 Antibody specifically binding to angiopoietin-2 and use thereof |
| 06/23/2011 | US20110150894 Methods of modulating angiogenesis via trpv4 |
| 06/23/2011 | US20110150893 Anti-trkb monoclonal antibodies and uses thereof |
| 06/23/2011 | US20110150892 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof |
| 06/23/2011 | US20110150891 Methods of Treating Interstitial Cystitis |
| 06/23/2011 | US20110150890 Use of cgrp antagonist compounds for treatment of psoriasis |
| 06/23/2011 | US20110150889 Haemophilus influenzae type iv pili |
| 06/23/2011 | US20110150888 Anti-hepcidin antibodies and methods of use |
| 06/23/2011 | US20110150887 Methods and products relating to gsk3beta regulation |
| 06/23/2011 | US20110150886 Anti-areg/hb-egf antibodies and treatment |
| 06/23/2011 | US20110150885 Aminoacyl trna synthetases for modulating hematopoiesis |
| 06/23/2011 | US20110150884 Crystalline composition of gm-csf/gm-csfr |
| 06/23/2011 | US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/23/2011 | US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 06/23/2011 | US20110150881 Inhibitors of extracellular hsp90 |
| 06/23/2011 | US20110150880 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 06/23/2011 | US20110150879 Specific depletion of cd4+ t cells |
| 06/23/2011 | US20110150878 Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal |
| 06/23/2011 | US20110150877 Ephrin-b receptor protein involved in carcinoma |
| 06/23/2011 | US20110150876 Prognosis and Treatment of Breast Cancer |
| 06/23/2011 | US20110150875 Egf-a domain-mediated modulation of pcks9 for treating lipid disorders |
| 06/23/2011 | US20110150874 Fusion proteins, uses thereof and processes for producing same |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150872 Soluble heterodimeric cytokine receptor |
| 06/23/2011 | US20110150871 Treatment of an autoimmune disease using il-18 antagonists |
| 06/23/2011 | US20110150870 Fully human anti-human nkg2d monoclonal antibodies |
| 06/23/2011 | US20110150869 Neuroinvasion Inhibitor |
| 06/23/2011 | US20110150868 Diagnostic and therapeutic methods and compositions involving pten and breast cancer |
| 06/23/2011 | US20110150867 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
| 06/23/2011 | US20110150865 Antibodies to lymphotoxin-alpha |
| 06/23/2011 | US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150862 Inhibitors of stim1 for the treatment of cardiovascular disorders |
| 06/23/2011 | US20110150861 Sorf constructs and multiple gene expression |
| 06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 06/23/2011 | US20110150859 method for selecting responders to blockade of integrin receptors |
| 06/23/2011 | US20110150833 Benzopyrans and analogs as rho kinase inhibitors |
| 06/23/2011 | US20110150832 Furin-knockdown bi-functional rna |
| 06/23/2011 | US20110150831 Novel naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/23/2011 | US20110150828 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof |
| 06/23/2011 | US20110150825 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
| 06/23/2011 | US20110150824 Nutritional Composition for Improving the Mammalian Immune System |
| 06/23/2011 | US20110150785 Light Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment |
| 06/23/2011 | US20110150778 Assembly of Gas-Filled Microvesicle With Active Component For Contrast Imaging |
| 06/23/2011 | US20110150776 Method for Testing and Treating Delayed Food Allergies |
| 06/23/2011 | US20110150773 Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150772 Modulators of carnitine octanoyltransferase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150770 Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine |
| 06/23/2011 | US20110150765 Frozen compositions and methods for piercing a substrate |
| 06/23/2011 | US20110150761 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders |
| 06/23/2011 | US20110150760 PRLR-Specific Antibody and Uses Thereof |
| 06/23/2011 | US20110150757 Compounds for inhibiting ksp kinesin activity |
| 06/23/2011 | CA2784784A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant |
| 06/23/2011 | CA2784093A1 Wise binding agents and epitopes |
| 06/23/2011 | CA2783969A1 A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy |
| 06/23/2011 | CA2781725A1 Methods of treating interstitial cystitis |
| 06/22/2011 | EP2336775A2 High affinity TCR proteins and methods |
| 06/22/2011 | EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/22/2011 | EP2336357A1 S. pneumoniae antigens |
| 06/22/2011 | EP2336322A1 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336190A2 Anti-VEGF antibodies |
| 06/22/2011 | EP2336189A1 Prostate cancer diagnosis and treatment |
| 06/22/2011 | EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 06/22/2011 | EP2336186A1 Humanized antibodies against ICAM-1, their production and uses |
| 06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
| 06/22/2011 | EP2336184A2 Administration of agents for the treatment of inflammation |
| 06/22/2011 | EP2336182A1 Treatment of TNF alpha related disorders |
| 06/22/2011 | EP2336180A1 Antibody specifically binding to angiopoietin-2 and use thereof |